↓ Skip to main content

Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review

Overview of attention for article published in Frontiers in Pharmacology, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
22 news outlets
blogs
3 blogs
twitter
14 X users
patent
3 patents
peer_reviews
1 peer review site
facebook
27 Facebook pages
wikipedia
1 Wikipedia page
googleplus
6 Google+ users
video
10 YouTube creators

Citations

dimensions_citation
375 Dimensions

Readers on

mendeley
776 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
Published in
Frontiers in Pharmacology, January 2012
DOI 10.3389/fphar.2012.00024
Pubmed ID
Authors

Majambu Mbikay

Abstract

Moringa oleifera (M. oleifera) is an angiosperm plant, native of the Indian subcontinent, where its various parts have been utilized throughout history as food and medicine. It is now cultivated in all tropical and sub-tropical regions of the world. The nutritional, prophylactic, and therapeutic virtues of this plant are being extolled on the Internet. Dietary consumption of its part is therein promoted as a strategy of personal health preservation and self-medication in various diseases. The enthusiasm for the health benefits of M. oleifera is in dire contrast with the scarcity of strong experimental and clinical evidence supporting them. Fortunately, the chasm is slowly being filled. In this article, I review current scientific data on the corrective potential of M. oleifera leaves in chronic hyperglycemia and dyslipidemia, as symptoms of diabetes and cardiovascular disease (CVD) risk. Reported studies in experimental animals and humans, although limited in number and variable in design, seem concordant in their support for this potential. However, before M. oleifera leaf formulations can be recommended as medication in the prevention or treatment of diabetes and CVD, it is necessary that the scientific basis of their efficacy, the therapeutic modalities of their administration and their possible side effects be more rigorously determined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 776 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ghana 2 <1%
South Africa 1 <1%
India 1 <1%
United Kingdom 1 <1%
Nigeria 1 <1%
Luxembourg 1 <1%
Unknown 769 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 107 14%
Student > Bachelor 107 14%
Student > Ph. D. Student 80 10%
Researcher 42 5%
Lecturer 41 5%
Other 154 20%
Unknown 245 32%
Readers by discipline Count As %
Agricultural and Biological Sciences 146 19%
Medicine and Dentistry 89 11%
Biochemistry, Genetics and Molecular Biology 66 9%
Pharmacology, Toxicology and Pharmaceutical Science 48 6%
Chemistry 39 5%
Other 117 15%
Unknown 271 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 223. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#179,256
of 26,143,998 outputs
Outputs from Frontiers in Pharmacology
#71
of 20,129 outputs
Outputs of similar age
#779
of 253,612 outputs
Outputs of similar age from Frontiers in Pharmacology
#2
of 149 outputs
Altmetric has tracked 26,143,998 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,129 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,612 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 149 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.